RxDoctor Payments Data

Margot Henderson

Medical · Kingman, AZNPI 1023092822

Payments from drug & device makers

$3,576in general payments, 2019–2025

Across 168 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$261
  • AstraZeneca$214
  • AbbVie$188
  • Sanofi$167
  • Daiichi Sankyo Inc.$147
  • Johnson & Johnson$145
  • plus $2K from 44 others

What the payments were for

  • Food & beverage$3,35994%
  • Education$2176%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,576 in reported general payments places this provider in the 80th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate27$463,598
EliquisApixaban49$51,326
XareltoRivaroxaban26$23,322
Hydroxyurea27$852
Ondansetron OdtOndansetron22$603
Letrozole22$400
Buspirone Hcl31$310
Escitalopram Oxalate18$247
Famotidine26$233
Azithromycin41$196
Duloxetine Hcl15$188
Warfarin Sodium31$184
Folic Acid20$128
Mupirocin14$107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationJakafi$140$463,59827 claims
PfizerEliquis$50$51,32649 claims
Johnson & JohnsonXarelto$145$23,32226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 748 medical providers in Arizona.

Other medical in Kingman

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →